Tectonic Therapeutic Inc. (TECX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tectonic Therapeutic Inc.

    NASDAQ: TECX · Real-Time Price · USD
    15.20
    0.49 (3.33%)
    At close: Sep 26, 2025, 3:59 PM
    15.20
    0.00%
    After-hours: Sep 26, 2025, 05:18 PM EDT

    Tectonic Therapeutic Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -57.98M -42.82M -32.18K -119.13M
    Depreciation & Amortization
    		 1.65M 617K 1.01K 1.4M
    Stock-Based Compensation
    		 3.49M 1.12M 1.12K 639.00
    Other Working Capital
    		 -8.86M 356.58K -4.3M 493K
    Other Non-Cash Items
    		 4.04M 404.42K -89.78M 18.4M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -10.28M -419 -7.4M 1.3M
    Operating Cash Flow
    		 -59.08M -40.68M -97.21M -98.03M
    Capital Expenditures
    		 -156K -279K -267K -2.46M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 -156K -279K -267K -2.46M
    Debt Repayment
    		 -475K -499K -393K 14.9M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 77.59M 121K 393K n/a
    Financial Cash Flow
    		 171.71M 33.75M 262K 30.37M
    Net Cash Flow
    		 112.47M -7.2M -96.72M -70.11M
    Free Cash Flow
    		 -59.24M -40.96M -97.47M -100.49M

    Add to Watchlist